30

Shenzhen Bioeasy Biotechnology Co LtdSHE 300942 Stock Report

Last reporting period 30 Sep, 2023

Updated 11 Nov, 2024

Last price

Market cap $B

2.057

Small

Exchange

XSHE - Shenzhen Stock Exchange

300942.SZ Stock Analysis

30

Uncovered

Shenzhen Bioeasy Biotechnology Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-18/100

Low score

Market cap $B

2.057

Dividend yield

0.16 %

Shares outstanding

400.86 B

Shenzhen Bioeasy Biotechnology Co., Ltd. engages in the research and development, production, and sale of food and drug safety and clinical diagnostic products. The company is headquartered in Shenzhen, Guangdong and currently employs 650 full-time employees. The company went IPO on 2021-02-09. The Company’s main products are food safety rapid testing reagents, rapid testing instruments, related testing services and in vitro diagnostic point-of-car testing (POCT) products, such as colloidal gold immunochromatographic test papers, enzyme-linked immunoassay (ELISA) kits, nucleic acids extraction kit, portable food rapid analysis system, infectious disease detection series and fluorescence immunoassay analyzer, etc. Its products are mainly used in dairy, meat, aquatic products, grains and oils, fruits and vegetables and other food fields that require rapid testing, as well as in the cultivation and breeding fields.

View Section: Eyestock Rating